176 related articles for article (PubMed ID: 12727218)
1. Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator.
Kim HK; Lee SY; Oh HK; Kang BH; Ku HJ; Lee Y; Shin JY; Hong YK; Joe YA
Biochem Biophys Res Commun; 2003 May; 304(4):740-6. PubMed ID: 12727218
[TBL] [Abstract][Full Text] [Related]
2. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
[TBL] [Abstract][Full Text] [Related]
4. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth.
Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M
J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456
[TBL] [Abstract][Full Text] [Related]
5. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
6. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2.
Carroll VA; Nikitenko LL; Bicknell R; Harris AL
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):736-41. PubMed ID: 15692103
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells.
Kim KS; Hong YK; Joe YA; Lee Y; Shin JY; Park HE; Lee IH; Lee SY; Kang DK; Chang SI; Chung SI
J Biol Chem; 2003 Mar; 278(13):11449-56. PubMed ID: 12529357
[TBL] [Abstract][Full Text] [Related]
9. Expression of the non-glycosylated kringle domain of tissue type plasminogen activator in Pichia and its anti-endothelial cell activity.
Lee SB; Oh HK; Kim HK; Joe YA
Protein Expr Purif; 2006 Nov; 50(1):1-8. PubMed ID: 16854593
[TBL] [Abstract][Full Text] [Related]
10. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
[TBL] [Abstract][Full Text] [Related]
11. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA
Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393
[TBL] [Abstract][Full Text] [Related]
12. [Molecular cloning and expression of the cDNA encoding angiogenesis inhibitor K4K5 with Pichia pastoris].
Guan XQ; Wang YX; Wu LC; Song HY
Sheng Wu Gong Cheng Xue Bao; 2001 Mar; 17(2):126-30. PubMed ID: 11411216
[TBL] [Abstract][Full Text] [Related]
13. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.
Liu L; Boffa MB; Koschinsky ML
PLoS One; 2013; 8(1):e52287. PubMed ID: 23326327
[TBL] [Abstract][Full Text] [Related]
16. The kringle domain of tissue-type plasminogen activator inhibits extracellular matrix-induced adhesion and migration of endothelial cells.
Lee BH; Kim HK; Joe YA
Biosci Biotechnol Biochem; 2008 Sep; 72(9):2303-8. PubMed ID: 18776698
[TBL] [Abstract][Full Text] [Related]
17. Kringle 1 of human hepatocyte growth factor inhibits bovine aortic endothelial cell proliferation stimulated by basic fibroblast growth factor and causes cell apoptosis.
Xin L; Xu R; Zhang Q; Li TP; Gan RB
Biochem Biophys Res Commun; 2000 Oct; 277(1):186-90. PubMed ID: 11027661
[TBL] [Abstract][Full Text] [Related]
18. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells.
Lu H; Dhanabal M; Volk R; Waterman MJ; Ramchandran R; Knebelmann B; Segal M; Sukhatme VP
Biochem Biophys Res Commun; 1999 May; 258(3):668-73. PubMed ID: 10329443
[TBL] [Abstract][Full Text] [Related]
19. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation.
Troyanovsky B; Levchenko T; Månsson G; Matvijenko O; Holmgren L
J Cell Biol; 2001 Mar; 152(6):1247-54. PubMed ID: 11257124
[TBL] [Abstract][Full Text] [Related]
20. Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen).
Goretzki L; Lombardo CR; Stallcup WB
J Biol Chem; 2000 Sep; 275(37):28625-33. PubMed ID: 10889192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
